XML 46 R13.htm IDEA: XBRL DOCUMENT
v3.25.4

Non-Controlling Interests | 12 Months Ended
--- | ---
Dec. 27, 2025
Noncontrolling Interest [Abstract] |
Non-Controlling Interests |
Note 4 : | Non-Controlling Interests
|  | Non-Controlling Ownership %
|  | Dec 27, 2025 |  | Dec 28, 2024
Ireland SCIP |  | 49 | % |  | 49 | %
Arizona SCIP |  | 49 | % |  | 49 | %
Mobileye |  | 20 | % |  | 12 | %
IMS Nanofabrication (IMS Nano) |  | 32 | % |  | 32 | %
(In Millions) |  | Ireland SCIP |  | Arizona SCIP |  | Mobileye |  | IMS Nano |  | Total
Non-controlling interests as of Dec 31, 2022 |  | $ | — |  |  | $ | 874 |  |  | $ | 989 |  |  | $ | — |  |  | $ | 1,863 |
Partner contributions |  | — |  |  | 1,511 |  |  | — |  |  | — |  |  | 1,511 |
Changes in equity of non-controlling interest holders |  | — |  |  | — |  |  | 848 |  |  | 167 |  |  | 1,015 |
Net income (loss) attributable to non-controlling interests |  | — |  |  | (26) |  |  | 1 |  |  | 11 |  |  | (14) |
Non-controlling interests as of Dec 30, 2023 |  | — |  |  | 2,359 |  |  | 1,838 |  |  | 178 |  |  | 4,375 |
Partner contributions |  | — |  |  | 1,702 |  |  | — |  |  | — |  |  | 1,702 |
Partner distributions |  | (43) |  |  | — |  |  | — |  |  | — |  |  | (43) |
Changes in equity of non-controlling interest holders |  | — |  |  | — |  |  | 205 |  |  | — |  |  | 205 |
Net income (loss) attributable to non-controlling interests |  | 104 |  |  | (173) |  |  | (371) |  |  | (37) |  |  | (477) |
Non-controlling interests as of Dec 28, 2024 |  | 61 |  |  | 3,888 |  |  | 1,672 |  |  | 141 |  |  | 5,762 |
Partner contributions |  | — |  |  | 5,108 |  |  | — |  |  | — |  |  | 5,108 |
Partner distributions |  | (217) |  |  | — |  |  | — |  |  | — |  |  | (217) |
Changes in equity of non-controlling interest holders |  | — |  |  | — |  |  | 1,133 |  |  | — |  |  | 1,133 |
Net income (loss) attributable to non-controlling interests |  | 268 |  |  | 110 |  |  | (57) |  |  | (28) |  |  | 293 |
Non-controlling interests as of Dec 27, 2025 |  | $ | 112 |  |  | $ | 9,106 |  |  | $ | 2,748 |  |  | $ | 113 |  |  | $ | 12,079 |
Semiconductor Co-Investment Program Ireland SCIP In the second quarter of 2024, we closed a transaction with Apollo involving the sale of 49% of our interest in an Irish limited liability company (Ireland SCIP) for net proceeds of $11.0 billion, which increased our capital in excess of par value. We consolidate the results of Ireland SCIP, a VIE, into our Consolidated Financial Statements because we are the primary beneficiary. Generally, distributions will be received from Ireland SCIP based on each investor's respective ownership of Ireland SCIP, of which Intel's is 51%. Ireland SCIP has rights to factory output of an Intel owned wafer fabrication plant in Ireland (Fab 34) and rights to resell the factory output to us. We retain sole ownership of Fab 34 and we are engaged as the Fab 34 operator in exchange for variable payments from Ireland SCIP based on the related factory output. We are required to substantially complete construction of Fab 34 in accordance with contractual parameters and timelines or we will be required to pay delay-related liquidated damages to Apollo, the other investor, beginning in 2026, not to exceed $1.1 billion in total. As of December 27, 2025 and December 28, 2024, we expected certain construction milestones for Fab 34 would be delayed as we refined our near-term production capacity requirements and related capital outlays relative to those that are required per the Ireland SCIP agreement. As a result, in 2024 we recognized a loss of $755 million within interest and other, net from the change in fair value of the liquidated damage provisions, which qualify as a non-designated derivative we recognized within other accrued liabilities for $179 million and other long-term liabilities for $576 million as of December 27, 2025 ($755 million in other long-term liabilities as of December 28, 2024). Refer to "Note 16: Derivative Financial Instruments" within Notes to Consolidated Financial Statements for additional information. Though we expect certain construction delays in the near term, we intend to complete construction of Fab 34. We will be required to purchase minimum quantities of the related factory output from Ireland SCIP, or we will be subject to certain volume-related damages payable to Ireland SCIP, beginning at the earlier of when construction is complete or the third quarter of 2027. As of December 27, 2025 and December 28, 2024, other than cash and cash equivalents held by Ireland SCIP, substantially all of the remaining assets and liabilities of Ireland SCIP were eliminated in our Consolidated Balance Sheets. Arizona SCIP We consolidate the results of an Arizona limited liability company (Arizona SCIP), a VIE, into our Consolidated Financial Statements because we are the primary beneficiary. Contributions and distributions made between Arizona SCIP and investors are generally made based on our and Brookfield's proportional ownership interest in Arizona SCIP. We are the primary beneficiary of two new chip factories still partially under construction by Arizona SCIP; we have the right to direct how and for what purpose the underlying assets will be used and to purchase 100% of the wafer output. During the year ended December 27, 2025, Arizona SCIP placed the first tranche of manufacturing assets into service, making the assets available for our use. When the production contract commences in 2026, as the sole operator we will be required to operate Arizona SCIP at minimum production levels and will be required to limit excess inventory held on site or we will be subject to certain volume-related damages payable to Arizona SCIP. The property, plant and equipment assets owned by Arizona SCIP and included in our Consolidated Balance Sheets as of December 27, 2025, which are not available to us as they can be used only to settle obligations of the VIE, consisted of construction in progress assets of $5.6 billion ($11.5 billion as of December 28, 2024) and assets that have been placed into service of $12.2 billion (none as of December 28, 2024). The remaining assets and liabilities of Arizona SCIP were eliminated in our Consolidated Balance Sheets. Mobileye We consolidate our majority owned subsidiary Mobileye pursuant to the voting interest model. In 2025, we converted 113.7 million of our Mobileye Class B shares into Class A shares. We subsequently sold 57.5 million of the Class A shares in a secondary offering, representing 7% of Mobileye's outstanding capital stock, for $16.50 per share and received net proceeds of $921 million. Concurrently, Mobileye repurchased from us 6.2 million of the Class A Shares for $16.50. As of December 27, 2025, we continue to hold the remaining 50.0 million Mobileye Class A shares from the conversion, in addition to our remaining Mobileye Class B shares. As we will continue to consolidate the results of Mobileye, the impact of their share repurchase was eliminated in our Consolidated Financial Statements. In the third quarter of 2024, the non-cash impairment of goodwill related to our Mobileye reporting unit was attributed to Intel and to non-controlling interest holders based on our proportional ownership (see "Note 11: Goodwill" within Notes to Consolidated Financial Statements). IMS Nanofabrication In 2023, we closed agreements to sell a combined 32% minority stake in our IMS business, which is part of our "all other" category. We continue to consolidate IMS results as a majority owned subsidiary pursuant to the voting interest model into our Consolidated Financial Statements.

X
- Definition The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 810 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/810/tableOfContent + Details
Name: | us-gaap_MinorityInterestDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_NoncontrollingInterestAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration